Biomason is the leading company in the world using biology to produce cement commercially. Since 2012, we’ve used natural microorganisms to grow structural Biocement® in ambient temperatures, harnessing the power of biotechnology to reinvent traditional cement and offer a more planet-friendly alternative. Biomason was founded in 2012 by Ginger Krieg Dosier and Michael Dosier as a solution to the carbon-intensity of the cement industry. Serving the global market with a focus in Europe and the Americas, we are headquartered in Research Triangle Park, North Carolina, United States. Our Concrete Development and Production Center houses state-of-the-art manufacturing technology to rapidly iterate new solutions while a fully operational team located in Ikast, Denmark services the global demand of Biocement® products. Our goal is for Biocement material to remove 25% of carbon emissions from the concrete industry by 2030.